key: cord-0428549-ukllmj8r authors: van Duijn, S.; Barsosio, H. C.; Omollo, M.; Milimo, E.; Odero, I. A.; Aroka, R.; de Sanctis, T.; K Oloo, A.; June, M. J.; Houben, N.; Wilming, C.; Otieno, K.; Kariuki, S.; Onsongo, S.; Odhiambo, A.; Rinke de Wit, T. title: Strengthening public COVID-19 response with private facilities in Kisumu, Kenya date: 2021-09-03 journal: nan DOI: 10.1101/2021.08.31.21262891 sha: d6c945ae94c748ecf497355eca69e71963ce7562 doc_id: 428549 cord_uid: ukllmj8r INTRODUCTION: SARS-CoV-2 testing is one of the options to combat COVID-19 in Kenya. In the first COVID-19 year there was limited tapping of the private sector's potential to scale up testing in Kenya. In April 2020, we initiated a unique public-private partnership (PPP) project in Kisumu County connecting the private sector to centralized testing supported by the ministry of health (MoH), COVID-Dx, to accelerate the local response to COVID-19. Within COVID-Dx, we aimed to demonstrate this PPP's performance as a replicable model for effective public-private collaboration in responding to the COVID-19 pandemic in similar settings. METHODS: KEMRI, Department of Health Kisumu County, PharmAccess Foundation, and local faith-based and private healthcare facilities collaborated in COVID-Dx. COVID-Dx was implemented from June 01, 2020, to March 31, 2021, in Kisumu County, Kenya. Trained laboratory technologists in participating healthcare facilities collected nasopharyngeal and oropharyngeal samples from patients meeting the MoH COVID-19 case definition. Samples were tested at the central laboratory in KEMRI via SARS-CoV-2 RT-PCR. Healthcare workers in participating facilities collected data using the digitized MoH COVID-19 Case Identification Form. We shared aggregated results from these data via (semi-) live dashboard to all relevant stakeholders. We did descriptive statistical analyses using Stata 16 to inform project processes. RESULTS: Nine facilities participated in the project. A total of 4,324 PCR tests for SARS-CoV-2 were done, with 425 positives. We noted differences in positivity rates between the facilities. Healthcare workers were the largest group tested in the project, 1009, representing 43% of the Kisumu healthcare workforce. CONCLUSION: COVID-Dx can serve as a model for PPPs scale-up testing, especially LMICs, and digitizing the MoH case report form improved reporting efficiency, demonstrating that digital is the way forward. The COVID-Dx PPP has led to another collaboration with Kisumu County aimed towards extending the COVID-Dx model to other counties. The private sector (for-profit, not-for-profit, and faith-based organizations) is a significant player in health service delivery in sub-Saharan Africa 11 . The private healthcare sector can add substantial capacity to the public health infrastructure, which often faces challenges in terms of quality of care, drug stockouts, health worker shortages, industrial action, and lack of diagnostic equipment 12 . Public-private partnerships (PPP) can play an essential role in LMICs health system development 9 , particularly during outbreaks and epidemics, where a coordinated, rapidly scalable approach is required (epidemic preparedness). The challenge is to combine private and public efforts in healthcare delivery in a mutually supportive and collaborative manner. Achieving a supportive PPP is complex. There are many examples of (inter)national responses where private healthcare sector initiatives were crowded out by parallel public sector efforts 13 . Crowding out implies that private investments in healthcare are replaced instead of supplemented by public funds, and the total amount of funds in the healthcare system remains unchanged. The Dutch NGO PharmAccess has gained extensive experience supporting innovative PPP models for healthcare 'crowding in' private funding. Notable PPP models include the first risk equalization fund for HIV in Africa 14 , the first Medical Credit Fund for Africa that provides loans to private-sector health entrepreneurs through public-private funding 15 and digital technologies provided through the M-TIBA platform to support Kisumu County's universal health coverage (UHC) 16 . Due to PharmAccess' experience with timely and generous donor contributions and necessary regulatory support by the local Department of Health, a unique joint PPP named "COVID-Dx" was started in early May 2020 in Kisumu County, Kenya, to enhance its capacity for COVID-19 sample collection and testing, data collection and timely reporting. We chose Kisumu County, located in the western part of Kenya, because of its unique track record as a county pioneering UHC using the M-TIBA digital platform 16 . The experience and ease of use of digital technologies in Kisumu via M-TIBA platforms placed the county in a . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) versus the gold standard RT-PCR. The results of this sub-study are reported in another paper 19 . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted September 3, 2021. ; https://doi.org/10.1101/2021.08.31.21262891 doi: medRxiv preprint The antigen testing procedure was carried out according to the manufacturer's specifications. The results were provided to patients within 15-30 minutes of testing. The CCIF-Tool digitized the official Kenyan COVID Case Identification Form (CCIF) used by MoH to screen and report all COVID-19 cases. In addition to collecting all essential clinical information, the CCIF-Tool enabled full tracking and tracing of samples and data: sample collection, courier receipt, transport, lab receipt, channeling into various KEMRI laboratories, result creation, result verification, reporting. The CCIF-Tool app data was stored in a dedicated database (CommCare), a robust mobile data collection and service delivery platform supported with application building services. CommCare is hosted in a highly secured ISO27001 environment and is also HIPAA and GDPR compliant. KEMRI provided oversight of scientific accuracy and quality of data. We shared aggregated results from the CommCare data via a PowerBI dashboard for information and decision-making by policymakers and relevant stakeholders. PowerBI is a collection of software services, apps and connectors that visualize interactive insights of data sources, which can be shared. The dashboard presented an overview of the characteristics of patients tested, positive patients, participating facilities, and maps with the patients per place of residence. Annex 1. is a screenshot of the dashboard. The dashboard was made available through passwordprotected restricted access on Smartphones for predetermined stakeholders. We conducted data analyses for operational purposes to inform project processes, monitor the progress of the project and generate data to inform policymakers and COVID-Dx partners. We did descriptive statistical analyses using Stata 16, tested relationships between categorical variables using a chi-square test, and used an independent sample t-test to explore relationships between categorical and continuous variables. We considered a p-value of <0.05 to be statistically significant during the analyses. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted September 3, 2021. In Table 2 , we present the roles of all four partners detailing each partner's responsibilities with collaboration occurring in many aspects. Choices regarding task division were based on the partners' different levels of authority, each partner's capabilities, such as time, knowledge about regulatory or laboratory processes, and staff available. Experience gained with projects set up in the past also informed roles. Generally, the DoH was responsible for approving selected participating facilities, providing guidelines regarding the case definition, contact tracing, and epidemic control guidelines. PharmAccess provided kickstart funding, managed the day-to-day operations of the project, psychosocial counselling, procurement, contact with facilities, and managed the data dashboard of the project. KEMRI provided supportive supervision, conducting social research and was responsible for the laboratory component. Healthcare facilities executed the sample taking, entered data into the CCIF-tool, assisted with contact tracing of COVID-19 patients, and disseminated the test results to patients. Annex 2 presents a Gantt Chart, outlining our key experiences during the implementation of COVID-Dx. The Gantt Chart shows we started project preparations before Kisumu County reported the first COVID-19 case on May 27, 2020. Although risky, starting early proved beneficial, because we were ready when the first COVID-19 cases emerged. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 3, 2021. Some months into the project, several healthcare facilities noticed fewer patients coming in to get tested. COVID-19 stigma turned out to be associated with hesitancy in testing and avoidance . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The overall COVID-19 positivity rate during the project was 9.8%. Figure 1 presents the weekly positivity rate based on PCR tests during project implementation. As shown, there were no COVID-19 cases found during the first months of the project (June 2020 and July 2020). We . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 1 noted a peak in COVID-19 cases in December 2020, which mirrored the Kenyan 'second wave', with a positivity rate of 23.1% at its highest point. Patient reported symptoms were captured using the CCIF-Tool. The most frequently reported symptoms from COVID-19 positive patients in order of frequency included cough, headache, general weakness, and history of fever/chills. The Gantt Chart (Annex 2) illustrates when each facility joined the COVID-Dx project. Facility The most-reported occupation of tested patients were healthcare workers (23.3%/n=1,009, representing 43% of the Kisumu healthcare workforce), being self-employed (12.5%/n=539) or being students (11.0%/n=476). We noted a positivity rate of 7.6% (n-77) among healthcare workers, which was slightly but significantly lower than the overall (9.8%) positivity rate (X 2 (1, N=4324) =7.5, P = 0.01). Moreover, 36% of tested healthcare workers who tested positive were asymptomatic. This study aimed to demonstrate the performance of a replicable model for an effective PPP in responding to the COVID-19 pandemic in a sub-Saharan African setting. Typically, COVID-19 responses in Africa are addressed through 'vertical' programs rolled out mainly through the public sector. This was done for HIV in the past, leading to parallel healthcare delivery and financing infrastructure in Africa and other LMICs, that is crucially dependent on international funding mechanisms through institutions like the GFATM and PEPFAR. Today, in the universal healthcare coverage (UHC) era, PharmAccess believes we should explore ways to 'horizontalize' vertical, disease-specific funds into primary healthcare delivery. This paper presents such a model: integrating private healthcare facilities into the public COVID-19 response. In Kenya, almost half of healthcare is delivered through private healthcare facilities. Therefore, at the onset of COVID-19, with then-unknown consequences, we opted for an immediate doubling of the healthcare capacity to deliver COVID-19 services by creating a PPP model. This was informed by our experience with HIV service delivery starting in the private sector in Africa and expanding to the public sector 20 . We had several challenges building the PPP. First, providing private healthcare facilities with access to public COVID-19 testing facilities through formalities at the national level proved lengthy (6 months). We mitigated this by opting for parallel expedited clearance at the County . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 3, 2021. ; https://doi.org/10.1101/2021.08.31.21262891 doi: medRxiv preprint level (1 month). Our general recommendation is Ethical Review processes should be fast-tracked during outbreaks as COVID-19. PPE supply for the healthcare facilities was another operational challenge. The essential PPE supplies were not readily available in Kenya when the project started. Eventually, we managed to procure some supplies to get started by paying approximately double the price of PPEs. The alternative of waiting a few months into the project for prices to fall was not tenable at the time, given the urgency to respond to the pandemic, and would have resulted in significant delays. Throughout the project, the supply chain of PPEs was restored, and prices went down. COVID-19 related stigma was an unexpected challenge. Some private facilities were afraid of being labelled COVID-19 testing sites. This fear was partially the result of (lockdown) measures implemented by government authorities early in the pandemic. When a public facility had staff who tested positive for COVID-19, they closed the facility. Additionally, the facilities hesitated to join COVID-Dx because they were afraid patients would avoid visiting the facility out of fear of being infected, which would also reduce the number of patients with chronic conditions. To mitigate these fears, we got a letter from the Kisumu County government in which they reassured the private facilities they would not be closed even if any of their patients tested positive for COVID-19. We also tried to convince facilities that their role in this pandemic was crucial. When the first facilities eventually joined, it created confidence for the other private facilities also to join. A lesson learnt was that COVID-19 stigma remained an issue throughout the project. Therefore, the project recruited a Psychosocial Counsellor who brought on board additional counsellors from the public and private sectors. These counsellors were trained HIV counsellors who adapted their training in HIV testing and addressing stigma to assist with pre-and post-test counselling for COVID-19 in their specific facilities. Counsellors underwent a training from the County's Mental Health and Psychosocial Support department. This intervention helped reducing fear, stigma, depression and other mental health related cases among the patients and health care workers. During COVID-Dx, decisions by public entities sometimes had consequences for the set research protocols and processes in the project. For instance, the MoH revised the national guidelines on COVID-19 testing throughout the project, and some sample taking sites closed unilaterally . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 3, 2021. ; 1 1 5 Dx in December 2020, when Kisumu was in the middle of the second wave. Therefore, compared to facilities that joined the project in the first few months, there were more COVID-19 patients. Facility I also showed interesting dynamics, as its first tests were performed in February of 2021, which was also in the period of more COVID-19 cases in the county, yet the positivity rate remained relatively low at 5.6%. Possibly because the testing volumes were high; 662 tests were done in two months. Facility E and F terminated the project in November 2020. COVID-19 politics within the county and ethical concerns in one of the facilities which did not align with the MoH code of ethics, were reasons to stop collaboration with these facilities. Looking at the positivity rates of all facilities over time, November 2020 had the lowest positivity rate. A temporary suspension in testing at some facilities, due to lack of PCR reagents and supplies at the central laboratories, could explain this low positivity rate. We noted rising positivity rates in March 2021 which mirrored the start of the third COVID-19 wave in Kisumu County. We considered healthcare workers a priority in the project, they were the largest group of tested cases in COVID-Dx (n=1,009, representing 43% of the Kisumu healthcare workforce). We tested healthcare workers involved in sample taking or who would be in close contact with potentially COVID-19 patients to detect possible cases among healthcare workers ahead of time. This was crucial, as a large proportion of patients carrying the virus were asymptomatic, hence there was a higher risk of close transmission to and among healthcare workers. Healthcare workers were also part of the case definition defined by the MoH to be eligible for COVID -19 testing. There were also some data limitations during this project. Developing the CommCare app was a continuous process, with constant improvements to adapt to the needs of the healthcare facilities, needs in sample tracking and transportation, and reporting needs from the laboratories. These changes sometimes affected how we presented the data in the final database. After extensive data cleaning, which was done manually regularly, the database issues were resolved in time for the final data analyses. Moreover, we tested patients according to the MoH national testing guidelines, meaning we were only allowed to test certain risk groups and symptomatic patients. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 3, 2021. ; Selective testing per MoH national guidelines was necessary in the absence of sufficient PCR tests available. However, the disadvantage of this was that the prevalence data we collected are not representative of the epidemiological situation in Kisumu County but somewhat biased toward positivity. While first focusing on building a good model for a PPP and assist with COVID-19 testing, we explored other opportunities to scale up testing. Early in the project, we found that large scale PCR testing had several limitations, such as high costs, requirement of trained staff, sophisticated equipment, and good logistics, which is often challenging in resource-poor settings. One of the constraints during COVID-Dx was the reporting of COVID-19 test results. We experienced delays, sometimes leading up to several weeks. From a patient's perspective, delayed results are highly frustrating due to the anxiety of waiting for a test and the impact on decision-making at the household level, such as whether to isolate from other family members. From an epidemiological perspective, delays in results reporting could also lead to an increased risk of transmission, as patients might unknowingly spread the virus while awaiting their results. Furthermore, we experienced regular stockouts of COVID-19 PCR test kits and KEMRI-CGHR was overloaded with samples from elsewhere, serving 36 other counties at one point when PCR machines from other central laboratories broke down. The above challenges led to a new development within the project, antigen testing. Rapid diagnostics tests (RDTs) for COVID-19 antigens can contribute to increased capacity for testing and scale up. The costs of RDTs are lower, results can be available within 20 minutes, no equipment is necessary, and less training is required. Therefore, we believed it could potentially be applied at point-of-care in facilities and within communities. A sub-study within COVID-Dx was implemented to validate RDTs and compare them to PCR tests. The results of this sub-study are published in a different paper 19 . RDTs could benefit the community more in testing for COVID-19 and contact tracing. Several studies already indicated that RDTs can be performed by community healthcare workers with proper training and supervision, as relatively few errors are made 27 . Furthermore, a device or an app reading the RDT test results could be an excellent opportunity to scale up the use of RDTs, which we also explored as a potential next step. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 3, 2021. ; Trust gained through COVID-Dx during the first part of the pandemic, led to a closer working relationship with Kisumu County to fight the next epidemic: the delta variant of the coronavirus, which was spreading fast in sub-Saharan Africa 3 We responded adequately to this third wave through the previously established partnership, a great example of epidemic preparedness. In conclusion, COVID-Dx has shown that setting up a PPP at the start of a global pandemic -COVID-19 -is challenging, but PPPs are essential for epidemic preparedness. This model is replicable and can serve as an example of PPPs for epidemic preparedness in similar settings in LMICs. Looking at the future of combatting epidemics, especially in LMICs, digital is the way going forward. Our efforts have led to developing a digital app with a corresponding dashboard, aggregating all the operational information in one place for decision-making. Hotspots can be identified in real-time, and outreach teams can be activated to target specific populations based on general characteristics. Moreover, it is transparent, enables data-driven decision-making, and provides insight into how to prioritize funding streams. This experience demonstrated that health systems need markedly improved efficiency and flexibility to respond to challenges that reoccur over time, such as epidemics. Going digital allows for this efficiency and flexibility in responsive health systems. Due to the privacy of patient data, datasets associated with this project are not publicly available. Anonymized and aggregated data are available from the authors upon request. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 3, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 3, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted September 3, 2021. ; COVID-19 Update 30th Rapid Global Spread of the SARS-CoV-2 Delta (B. 1.617. 2) Variant: Spatiotemporal Variation and Public Health Impact COVID-19 variants fuel Africa's surging wave Kenya receives COVID-19 vaccines and launches landmark national campaign Assessing the level and determinants of COVID-19 Vaccine Confidence in Kenya COVID-19 Vaccine Deployment-Overview & Rollout Plan. Planning & Coordination Covid-19 Vaccines Deployment and Vaccination Taskforce Herd Immunity: Understanding COVID-19 A new paradigm for increased access to healthcare in Africa Innovation in Namibia: preserving private health insurance and HIV/AIDS treatment Convergence. Case study: Medical Credit Fund (MCF) County Government of Kisumu signs a new partnership to establish a scheme for those who cannot afford health insurance Kisumu County: Department of Health & Sanitation Interim Guidelines on Management of COVID-19 in Kenya Ministry of Health Kenya Field performance of NowCheck rapid antigen test for SARS-CoV-2 in Kisumu County, western Kenya HAART for the HIV-infected employees of large companies in Africa The authors would like to express gratitude to all clinicians, nurses, lab technicians, motorbike riders, data entry personnel and all other personnel who were active in the field during this study.We would also like to thank the Kisumu Department of Health for its permission and cooperation to execute this project. Lastly, we would like to thank our funders: Achmea Foundation, Pfizer Foundation, and the Netherlands Ministry of Foreign Affairs. The authors have declared no competing interests.